CLEVELAND BIOLABS INC (CBLI) is a publicly traded company in the Unknown sector. Across all available filings, 19 corporate insiders have executed 272 transactions totaling $1.4M, demonstrating a bearish sentiment with -$899.8K in net insider flow. The most recent transaction on Jul 27, 2021 involved a transaction of 141,370 shares valued at $0.
No significant insider buying has been recorded for CBLI in the recent period.
No significant insider selling has been recorded for CBLI in the recent period.
Based on recent SEC filings, insider sentiment for CBLI is bearish with an Insider Alignment Score of 18/100 and a net flow of -$899.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at CLEVELAND BIOLABS INC (CBLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 19 insiders are actively trading CBLI stock, having executed 272 transactions in the past 90 days. The most active insider is Michael Fonstein (Executive), who has made 64 transactions totaling $484.9K.
Get notified when executives and directors at CBLI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jul 27, 2021 | Aronstam Peter | Executive | Award | 141,370 | $N/A | $0 | |
| Jul 27, 2021 | M. Mcavoy Cozette | Executive | Award | 60,947 | $N/A | $0 | |
| Jul 27, 2021 | Selsky Clifford | Executive | Award | 101,579 | $N/A | $0 | |
| Jul 27, 2021 | Buckheit Robert | Executive | Award | 24,378 | $N/A | $0 | |
| Jul 27, 2021 | K. Handley Michael | Executive | Award | 296,609 | $N/A | $0 | |
| Jul 22, 2021 | L. Miller Langdon | Executive | Option Exercise | 10,000 | $3.00 | $30.0K | |
| Feb 25, 2015 | S. Saluck Randy | Executive | Purchase | 1,891 | $3.42 | $6.5K | |
| Jan 8, 2015 | Principi Anthony | Executive | Award | 37,947 | $0.30 | $11.4K | |
| Jan 8, 2015 | R. Brown Julia | Executive | Award | 62,500 | $0.30 | $18.8K | |
| Oct 1, 2014 | R. Brown Julia | Executive | Award | 1,903 | $9.20 | $17.5K | |
| Mar 13, 2014 | C. Hohn David | Executive | Award | 22,978 | $0.68 | $15.6K | |
| Jun 19, 2013 | C. Hohn David | Executive | Award | 10,487 | $N/A | $0 | |
| Jun 19, 2013 | E. Dicorleto Paul | Executive | Award | 10,102 | $N/A | $0 | |
| Jun 19, 2013 | R. Brown Julia | Executive | Award | 15,939 | $N/A | $0 | |
| Jun 19, 2013 | Principi Anthony | Executive | Award | 14,472 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 208 | $1.2M | 76.7% |
Purchase(P) | 30 | $257.6K | 17.1% |
Award(A) | 31 | $63.3K | 4.2% |
Exercise(M) | 1 | $30.0K | 2.0% |
Gift(G) | 2 | $0 | 0.0% |
Insider selling pressure at CLEVELAND BIOLABS INC has increased, with 19 insiders executing 272 transactions across all time. Total sales of $1.2M significantly outpace purchases of $257.6K, resulting in a net outflow of $899.8K. This selling activity appears largely discretionary, which may warrant closer attention from investors.